A resistance training review keeps MGF in the IGF-1 exercise story

The review pulled together 26 research articles on how resistance training variables and nutrition influence the IGF-1 axis in sedentary people ¹. It places MGF among the local IGF-1 isoforms that are part of that axis, but it does not report new MGF measurements ¹. The main finding is that low-load training, around 20 to 30 percent of a person's one-repetition maximum, can activate the mTOR pathway, a cellular growth pathway that controls protein synthesis, as effectively as traditional high-load training when blood flow restriction or slow-motion techniques are used ¹. For beginners, low-load protocols with blood flow restriction or slow-motion work tap the same mTOR pathway as heavy lifting ¹. The review also notes that low-load methods may reduce the roughly 20 percent drop in arterial compliance often linked to heavy lifting ¹. Longer rest intervals of about three minutes and evening workouts are described as supportive for adaptation ¹. The review also reports that during exercise, up to 88 percent of cardiac output can be redirected to skeletal muscle ¹. A nutrigenetic detail is that people carrying the T version of a common gene variant called rs6214 showed greater visceral fat loss when resistance training was paired with daily dairy consumption ¹.

The first unrelated study tested mangiferin monosodium salt, a compound abbreviated MG-Na, in rats with alcohol-induced liver disease ². It found that MG-Na improved liver function and intestinal barrier integrity and shifted the diversity and richness of gut microbiota ². The study also reported changes in a copper-dependent form of cell death called cuproptosis, plus lower levels of inflammatory signals such as IFN-beta, TNF-alpha, IL-1 beta, and IL-6 ². The MG-Na treatment downregulated proteins involved in cuproptosis, including FDX1 and DLAT, and reduced cGAS-STING and TLR4/NF-kB/NLRP3 pathway activity ². It also reduced fecal metabolites such as (R)-lipoic acid and pyruvic acid in the alcohol-fed rats ². The compound reduced proteins involved in alcohol metabolism, including ADH1 and CYP2E1, and changed activity in the TCA cycle ². But the compound is not mechano growth factor, and no MGF pathway was tested ².

The second study looked at ginger-processed anemarrhenae rhizoma, an herb preparation ³. It identified chemical differences after processing and predicted that key components could bind to NF-kB and COX-2 proteins involved in inflammation ³. In a macrophage inflammation model, the preparation reduced TNF-alpha and IL-6 levels ³. This study also did not involve MGF ³.

Mechano growth factor is a splice variant of the insulin-like growth factor 1 gene ⁴. Unlike the circulating form of IGF-1, MGF is produced locally when tissues are mechanically loaded, injured, or starved of oxygen ⁴. MGF carries a unique E-domain tail that lets it signal through pathways that are partly independent of the classic IGF-1 receptor ⁴. The new review includes MGF among the local IGF-1 isoforms it considers, but it does not separate MGF-specific results from the broader IGF-1 axis ¹. Earlier research showed that androgen signaling can increase MGF expression in muscle as part of a broader anabolic program ⁷. So the review's placement is consistent with older data, but it does not add direct MGF evidence ¹.

Direct MGF research remains preclinical. In mice, a synthetic E-domain peptide from MGF reduced cell death and preserved heart function after an experimentally induced heart attack ⁸. In a rabbit model, MGF accelerated repair of the anterior cruciate ligament and improved movement of mechanically injured human ligament cells ⁹. In cartilage cells under low oxygen, pretreatment with an MGF E peptide improved cell proliferation and extracellular matrix production ¹⁰. In osteoarthritis models, MGF slowed joint degeneration in rabbits ¹¹. In bone research, MGF promoted proliferation and osteogenic differentiation of rabbit mesenchymal stem cells ¹² and enhanced bone-defect healing in rabbits ¹³. In the aging mouse brain, MGF increased the growth of new neurons in regions linked to memory and smell ¹⁴. MGF also promoted migration of human mesenchymal stem cells, which are used in tissue engineering ¹⁵. These studies provide the main body of direct MGF evidence, and none of them are human trials ⁴.

The limitation is that the new review names MGF without measuring it ¹. The review's results describe the IGF-1 axis as a whole, and MGF is only one part of that axis ¹. It cannot tell us whether low-load training changes MGF levels or activity in human muscle ¹. The two other studies are not MGF research, so they cannot close that gap ². For a reader, this means the new batch does not add MGF-specific findings ¹.

No controlled human efficacy trials for MGF exist ⁴. The direct MGF studies use cell cultures or animals, and safe duration, long-term risks, and interactions with common medications remain unstudied in humans ⁴. The new review does not provide MGF-specific measurements ¹. The liver and herb studies do not involve MGF, so they cannot inform MGF's effects ². For now, the direct MGF picture is unchanged: it is a local repair signal with animal and cell findings, but no human data ⁴.